The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

Blood Flow Restriction Clinical Trial

Official title: The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

Status Completed

Clinical Trial Summary

The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare performance outcomes and blood markers among two intervention groups (BFR and BFR+Arg) and a control group (CON).

Clinical Trial Description

The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare performance outcomes and blood markers among two intervention groups (BFR and BFR+Arg) and a control group (CON). All group will participate in the same training regimen. The control group will train and ingest a placebo pill. The BFR group will train with BFR and ingest a placebo pill, and the BFR+Arg group will train with BFR and ingest an L-arginine pill. All placebo pills will be Maltodextrin. The performance outcome is leg press 1RM, while the blood markers are growth hormone (GH) and cortisol. This analysis will provide insight as to whether or not L-arginine supplementation in addition to blood flow restriction training improves performance and muscle hypertrophy measure more than blood flow restriction training alone. ;

Related Conditions & MeSH terms

• Arginine
• Blood Flow Restriction
• Growth Hormone
• Strength Outcomes

• NCT number: NCT04079010
• Study type: Interventional
• Source: University of Mary Hardin-Baylor
• Status: Completed
• Phase: N/A
• Start date: September 4, 2019
• Completion date: November 25, 2019